Day: August 28, 2023

Company announcement 30/2023 Sebastian Koks Andreassen resigns as CEO of Green Hydrogen Systems Kolding, Denmark, 28 August 2023 – Today, Green Hydrogen Systems has received the resignation from Sebastian Koks Andreassen, Chief Executive Officer (CEO) of the company. The resignation follows Sebastian Koks Andreassen’s decision to take on a new position with Copenhagen Infrastructure Partners. Sebastian Koks Andreassen continues as CEO until a successor is found, ensuring a smooth transition. The process to find a new CEO for Green Hydrogen Systems A/S, will be initiated immediately. For more info please contact: Investors: Jens Holm Binger, Head of Investor Relations, +45 6065 6525, jhb@greenhydrogen.dk Media: Jesper Buhl, Head of Public Affairs and Media Relations, +45 5351 5295, jbu@greenhydrogen.dk Green Hydrogen Systems in brief Green...

PRESS RELEASE: 28 August 2023, 7:00 AM CEST Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders Mechelen, Belgium, 28 August 2023 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), is pleased to announce the appointment of a global Medical Advisory Board (MAB) comprised on renowned and influential KOLs in diagnostics, pharma and hospitals to advise, inform and guide Biocartis’ expedited global growth in the area of diagnostic partnerships and to provide valuable expert technology insights (e.g. complementarity of Idylla™ with NGS or other technologies), expert knowledge on the clinical diagnostic needs in the field of oncology (e.g. regulatory insights, advocacy groups) and expert guidance on defining future strategies for...

Saint-Herblain (France), August 28, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported positive initial Phase 3 safety data in adolescents for its single-dose chikungunya virus (CHIKV) vaccine candidate VLA1553. Immunogenicity data for the trial are expected in November 2023. Funded by the Coalition for Epidemic Preparedness Innovations (CEPI) and conducted in collaboration with Instituto Butantan, the VLA1553-321 adolescent trial is intended to support label extension in this age group following a potential initial regulatory approval in adults from the Food and Drug Administration (FDA) in the United States (U.S). The trial is also expected to support licensure of the vaccine in Brazil, which would be the first potential approval for use in endemic populations. The present safety analysis...

Sandoz completes acquisition of worldwide brand rights for Mycamine® (micafungin sodium) from Astellas Leading global echinocandin, one of three major antifungal classes, will significantly reinforce Sandoz hospital offering and leading anti-infectives portfolioAddition of Mycamine ® will support Sandoz drive to ensure responsible use of antimicrobials, through targeted use of most appropriate therapiesBasel, August 28, 2023 – Sandoz, a global leader in generic and biosimilar medicines, has successfully completed the acquisition of worldwide brand rights for leading systemic antifungal agent Mycamine ® (micafungin sodium, Funguard® in Japan) from Astellas. Through this acquisition of the leading global echinocandin, one of three major antifungal classes, Sandoz significantly reinforces its global hospital offering and leading...

On 25.08.2023, Hepsor Latvia OÜ, a subsidiary of Hepsor AS, signed a share purchase agreement, which will acquire 50% of the shares of SIA “Riga Properties 4”. SIA “Riga Properties 4” has signed a purchase agreements for the purchase of two properties in the Riga district of Latvia located at “Līdumi”, Dreiliņi, Stopiņu rural municipality, Ropažu nov., LV-2130 with a total area of 74,314 m2 and the company’s goal is to develop approximately 40,000 m2 of commercial premises on these properties in stages. “Hepsor is pleased to announce starting a new commercial real estate project on the Riga market, where only recently we completed a successful sales transaction of a stock-office-type commercial building” said Henri Laks, Member of the Management Board. “The properties are located...